Year archive

Knight Therapeutics Inc. — 2023 filings

All 27 regulatory filings released by Knight Therapeutics Inc. (GUD) in 2023, sourced directly from the official regulator.

27 Filings

2023 Period

2023 filings (27)

Filing	Released	Lang
52-109F2 - Certification of interim filings - CFO (E).pdf Capital/Financing Update	2023-11-09	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-11-09	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2023-11-09	English
Interim MD&A - English.pdf Interim / Quarterly Report	2023-11-09	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2023-11-09	English
News release - English.pdf Interim / Quarterly Report	2023-11-09	English
News release - French.pdf Interim / Quarterly Report	2023-11-09	English
Interim MD&A - English.pdf Interim / Quarterly Report	2023-08-10	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-08-10	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2023-08-10	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2023-08-10	English
News release - French.pdf Interim / Quarterly Report	2023-08-10	English
News release - English.pdf Interim / Quarterly Report	2023-08-10	English
News release - French.pdf Declaration of Voting Results & Voting Rights Announcements	2023-05-11	English
News release - English.pdf Declaration of Voting Results & Voting Rights Announcements	2023-05-11	English
Notice of meeting - French.pdf AGM Information	2023-04-06	English
Annual report - English.pdf Regulatory Filings	2023-04-04	English
News release - French.pdf Annual Report	2023-03-29	English
Material contracts - Credit agreements.pdf Capital/Financing Update	2023-03-29	English
Annual information form - English.pdf Annual Report	2023-03-29	English
52-109F1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2023-03-29	English
52-109F1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2023-03-29	English
Annual MD&A - English.pdf Management Reports	2023-03-29	English
Audited annual financial statements – English.pdf Audit Report / Information	2023-03-29	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf Report Publication Announcement	2023-03-29	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2023-03-29	English
News release - English.pdf Annual Report	2023-03-23	English